I started supporting SENS pretty early, so I had to actually go read the primary literature and take a few years to figure out that yes, I think that this is the best fulcrum to make progress in changing the research community, building the right tech, etc.
Nowadays, you can actually rely upon more distributed middle man expertise. E.g. that Peter Thiel invested millions in SENS, or that the SRF advisory board includes numerous researchers who are at the tops of their fields, names appearing in the media, all of whom endorse the SENS approach (http://sens.org/about/leadership/research-advisory-board), and so on and so forth.
What is telling and makes it clear that this organization (not going to discuss the cause, but this specific organization) is that there are NO people of color on the advisory board and only one person of color on the board of directors. The board of directors also is entirely startup founders, venture capitalists, and other entrepreneurs.
Without diversity at the leadership level, it is fairly easy to assume (externally) that this organization is working to solve aging related illnesses for the 1%.
If I had to choose between contributing 0.1% of the cost of a project that has a 1% chance of saving 100,000 lives a day (effectively saving 1.0 lives a day), versus contributing 0.2% of the cost of a project that has a 60% chance of saving 1,000 lives a day (effectively saving 1.2 lives a day), I might choose the latter.